These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17889314)

  • 1. Bupropion and nicotine patch as smoking cessation aids in alcoholics.
    Grant KM; Kelley SS; Smith LM; Agrawal S; Meyer JR; Romberger DJ
    Alcohol; 2007 Aug; 41(5):381-91. PubMed ID: 17889314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
    Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
    Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
    Jamerson BD; Nides M; Jorenby DE; Donahue R; Garrett P; Johnston JA; Fiore MC; Rennard SI; Leischow SJ
    Clin Ther; 2001 May; 23(5):744-52. PubMed ID: 11394732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for tobacco dependence.
    Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to nicotine dependence treatment in smokers with current and past alcohol problems.
    Hays JT; Schroeder DR; Offord KP; Croghan IT; Patten CA; Hurt RD; Jorenby DE; Fiore MC
    Ann Behav Med; 1999; 21(3):244-50. PubMed ID: 10626032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
    Piper ME; Smith SS; Schlam TR; Fiore MC; Jorenby DE; Fraser D; Baker TB
    Arch Gen Psychiatry; 2009 Nov; 66(11):1253-62. PubMed ID: 19884613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion sustained release and smoking cessation.
    Goldstein MG
    J Clin Psychiatry; 1998; 59 Suppl 4():66-72. PubMed ID: 9554323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
    Hays JT; Hurt RD; Decker PA; Croghan IT; Offord KP; Patten CA
    Nicotine Tob Res; 2009 Jul; 11(7):859-67. PubMed ID: 19483180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bupropion alone and in combination with nicotine gum.
    Piper ME; Federman EB; McCarthy DE; Bolt DM; Smith SS; Fiore MC; Baker TB
    Nicotine Tob Res; 2007 Sep; 9(9):947-54. PubMed ID: 17763111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.